Free Trial

Appili Therapeutics Q3 2024 Earnings Report

Appili Therapeutics logo
$0.03 +0.00 (+0.39%)
(As of 12/20/2024 05:55 PM ET)

Appili Therapeutics EPS Results

Actual EPS
-$0.01
Consensus EPS
-$0.01
Beat/Miss
Met Expectations
One Year Ago EPS
N/A

Appili Therapeutics Revenue Results

Actual Revenue
$0.36 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Appili Therapeutics Announcement Details

Quarter
Q3 2024
Time
Q3 2024 Earnings Release

Conference Call Resources

Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment (Ad)

This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.

Click here for the ticker >>>

Appili Therapeutics Earnings Headlines

Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment
This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.
See More Appili Therapeutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Appili Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Appili Therapeutics and other key companies, straight to your email.

About Appili Therapeutics

Appili Therapeutics (OTCMKTS:APLIF), a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada. Its anti-infective portfolio includes ATI-1501, a taste-masked liquid oral suspension formulation of the antibiotic metronidazole to treat anaerobic bacterial, protozoal, and parasitic infections; ATI-1801, a novel topical formulation of paromomycin in Phase III clinical trials for the treatment of cutaneous leishmaniasis and disfiguring skin infections; and ATI-1701, which is a live-attenuated vaccine in preclinical trials for Francisella tularensis. The company was incorporated in 2015 and is headquartered in Halifax, Canada.

View Appili Therapeutics Profile

More Earnings Resources from MarketBeat

Upcoming Earnings